Skip to main content
. 2023 Jul 7;102(27):e34122. doi: 10.1097/MD.0000000000034122

Figure 3.

Figure 3.

Lague of inclined interventions in evaluating change of HBA1C (A) and weight (B). Data in each cell are hazard or odds ratios (95% credible intervals) for the comparison of row-defining treatment versus column-defining treatment. Significant results are marked*. Dula = dulaglutide, Exe = exenatide, HbA1c = glycosylated hemoglobin type A1C, Sema = Semaglutide.